Crossmark

State-of-the-art iron-based nanozymes for biocatalytic tumor therapy

Crossref DOI link: https://doi.org/10.1039/C9NH00577C

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Li, Menghuan

Zhang, Hui

Hou, Yanhua

Wang, Xuan

Xue, Chencheng

Li, Wei

Cai, Kaiyong https://orcid.org/0000-0001-9029-680X
Zhao, Yanli https://orcid.org/0000-0002-9231-8360
Luo, Zhong https://orcid.org/0000-0002-9019-3314
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (11832008, 51602034, 51603024, 51773023)

National Basic Research Program of China (2017YFB0702603, 2016YFC1100300)

Fundamental Research Funds for the Central Universities (2018CDQYSM0036, 2019CDYGYB004)

Chongqing Science and Technology Commission (cstc2017shmsA1089)

Chongqing Research Program of Basic Research and Frontier Technology (cstc2018jcyjAX0580)

Agency for Science, Technology and Research (A1883c0005)

National Research Foundation Singapore (NRF-NRFI2018-03)
License Information

Accepted Manuscript valid from 2020-11-05
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Kaiyong Cai (ORCID)

: Yanli Zhao (ORCID)

: Yanli Zhao (ResearcherID)

: Zhong Luo (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 2 September 2019; Accepted 4 November 2019; Accepted Manuscript published 5 November 2019; Advance Article published 21 November 2019; Version of Record published 3 February 2020